Cargando…
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
Autores principales: | Tilangi, Praveen, Desai, Devashish, Khan, Adil, Soneja, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255125/ https://www.ncbi.nlm.nih.gov/pubmed/32450054 http://dx.doi.org/10.1016/S1473-3099(20)30430-8 |
Ejemplares similares
-
False reassurance or inadequate drug levels?
por: Tirlangi, Praveen, et al.
Publicado: (2020) -
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020) -
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
por: Kadnur, Harshith B., et al.
Publicado: (2022) -
Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020) -
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)